Search Within

Gunjan Lalitchandra Shah

Formats
  1. Meeting Abstract (272)
  2. Journal Article (124)
  3. Research Letter (13)
  4. Review (6)
  5. Correspondence (2)
  6. Guidelines (1)
Groups
  1. Bone Marrow Transplant (418)
  2. Center for Hematologic Malignancies (418)
  3. Department of Medicine (418)
  4. Hematologic Malignancies, Division of (418)
  5. Survivorship Research (418)
  6. CTCR Scholars (321)

More Groups

People
  1. Sergio Giralt (297)
  2. Michael Scordo (277)
  3. Miguel-Angel Perales (192)
  4. Sean Devlin (177)
  5. Parastoo Dahi (155)
  6. Heather Landau (154)

More People

Years
  1. 2025 (12)
  2. 2024 (54)
  3. 2023 (85)
  4. 2022 (55)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Blood (137)
  2. Biology of Blood and Marrow Transplantation (73)
  3. Clinical Lymphoma, Myeloma and Leukemia (39)
  4. Transplantation and Cellular Therapy (23)
  5. Blood Advances (20)
  6. Bone Marrow Transplantation (19)

More Publications

Publishers
  1. American Society of Hematology (157)
  2. Elsevier Inc. (142)
  3. Nature Publishing Group (31)
  4. American Society of Clinical Oncology (14)
  5. Taylor & Francis Group (9)
  6. Wiley Blackwell (7)

More Publishers

Results (418)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cell therapy for myeloma: Where are we now and what is needed to move chimeric antigen receptor T cells forward to earlier lines of therapy? Expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Guidelines

    Anderson, L. D. Jr; Dhakal, B.; Jain, T.; Oluwole, O. O.; Shah, G. L.; Sidana, S.; Perales, M. A.; Pasquini, M. C.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Determination of busulfan and melphalan in plasma by turbulent flow chromatography-tandem mass spectrometry
    Journal Article

    Schofield, R. C.; Scordo, M.; Shah, G.; Carlow, D. C.
    Methods in Molecular Biology (2024)

    Fulltext@MSK | Save
  • Quantification of clofarabine and fludarabine in plasma by high-performance liquid chromatography-tandem mass spectrometry
    Journal Article

    Schofield, R. C.; Scordo, M.; Shah, G.; Carlow, D. C.
    Methods in Molecular Biology (2024)

    Fulltext@MSK | Save
  • Simultaneous determination of prednisone and prednisolone in serum by turbulent flow liquid chromatography-tandem mass spectrometry
    Journal Article

    Schofield, R. C.; Scordo, M.; Shah, G.; Carlow, D. C.
    Methods in Molecular Biology (2024)

    Fulltext@MSK | Save
  • Measurement of thioTEPA and its metabolite TEPA in plasma and cerebrospinal fluid by turbulent flow chromatography-tandem mass spectrometry
    Journal Article

    Schofield, R. C.; Scordo, M.; Shah, G.; Carlow, D. C.
    Methods in Molecular Biology (2024)

    Fulltext@MSK | Save
  • Real-world tisagenlecleucel outcomes in Richter-transformed chronic lymphocytic leukemia: A Center for International Blood & Marrow Transplant Research (CIBMTR) analysis
    Meeting Abstract

    Shadman, M.; Frigault, M. J.; Foley, S. R.; Hill, B. T.; Schofield, G.; Jacobson, C.; Jaglowski, S. M.; Locke, F. L.; Landsburg, D. J.; Ram, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Durable efficacy and manageable safety in patients ageā‰„75 years with relapsed/refractory large B-cell lymphoma treated with tisagenlecleucel in the real-world setting
    Meeting Abstract

    Landsburg, D. J.; Heim, M.; Moskop, A.; Foley, S. R.; Hill, B. T.; Schofield, G.; Jacobson, C.; Jaglowski, S. M.; Locke, F. L.; Ram, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save